계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
CytoPherx
company
About
CytoPherx is a medical device company offering a proprietary selective cytopheresis sytem for inflammation-based diseases and conditions.
- 1 - 10
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- $11.70M
- Industries
- Health Care,Life Science,Medical Device
- Founded date
- Jan 1, 2007
- Number Of Employee
- 1 - 10
- Operating Status
- Active
CytoPherx (formerly Nephrion) clinical stage medical device company addressing inflammation-based diseases and conditions. The company’s products are custom configurations of a proprietary selective cytopheresis-based inflammation modulating system.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$11.70M
CytoPherx has raised a total of
$11.70M
in funding over 2 rounds. Their latest funding was raised on
Jun 17, 2010 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 17, 2010 | Series B | $11.70M | 1 |
Diamond Capital Management
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
CytoPherx is funded by 1 investors.
Diamond Capital Management
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Diamond Capital Management
|
Yes | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
